U.S. market Closed. Opens in 1 day 4 hours 6 minutes

LUMO | Lumos Pharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenue2.05M1.52M230.00K168.00K936.00K1.21M390.00K3.53M36.14M165.95M1.09M1.69M1.87M2.08M934.00K633.00KN/A
Cost of RevenueN/A49.00KN/AN/A37.00K-11.27M1.41MN/A-32.36M-6.64MN/AN/AN/AN/AN/AN/A235.00K
Gross Profit2.05M1.47M230.00K168.00K899.00K12.47M-1.02M3.53M68.50M172.59M1.09M1.69M1.87M2.08M934.00K633.00K-235.00K
Operating Expenses38.66M33.56M31.58M26.47M46.07M63.64M73.27M94.28M69.75M48.38M31.14M23.26M19.93M18.74M10.75M10.05M7.88M
Selling, General & Admin16.57M15.71M15.33M17.27M23.86M29.22M31.73M33.23M30.69M19.33M9.52M7.11M5.68M6.07M5.19M4.60M3.12M
Research & Development22.10M17.86M16.25M9.21M22.20M45.69M69.87M93.30M71.41M35.69M22.71M17.84M14.26M12.67M5.56M5.45M4.77M
Other Operating ExpensesN/A91.00K269.00K6.47M-19.00K-102.00K371.00K247.00K-41.00K60.00K91.00K-62.00KN/AN/AN/AN/AN/A
Operating Income-36.61M-32.04M-31.35M-26.30M-45.13M-62.44M-72.88M-90.76M-33.60M117.57M-31.14M-23.26M-18.06M-16.66M-9.82M-9.41M-8.12M
Other Expenses / Income2.55M965.00K281.00K6.67M35.43M1.88M371.00K247.00K-41.00K60.00K91.00K-62.00K-25.00K99.00K142.00K573.00K540.00K
Before Tax Income-34.06M-31.07M-31.07M-19.64M-42.98M-60.56M-72.51M-90.51M-33.64M117.63M-31.05M-23.32M-18.09M-16.59M-9.80M-9.37M-7.58M
Income Tax Expenses-29.00K-13.00K-636.00K-13.97M12.00K-6.97M-559.00K-5.36M6.74M14.78M130.00K-788.00K41.00K-448.00K-375.00K-253.00KN/A
Net Income-34.03M-31.06M-30.43M-5.66M-42.99M-53.59M-71.95M-85.16M-40.38M102.86M-31.18M-23.32M-18.09M-16.21M-9.44M-9.16M-7.58M
Interest ExpensesN/A874.00KN/AN/A50.00K52.00K119.00K22.00K105.00K26.00K33.00K38.00K42.00K47.00K9.00K2.00K1.00K
Basic Shares Outstanding8.15M8.37M8.33M6.78M144.71K4.13M3.48M3.22M3.18M3.09M2.81M2.31M673.84K1.60M1.60M1.60M2.39M
Diluted Shares Outstanding8.15M8.37M8.33M6.78M144.71K4.13M3.48M3.22M3.18M3.45M2.81M2.31M673.84K1.60M1.60M1.60M2.39M
EBITDA-36.57M-31.99M-31.13M-25.72M-45.13M-59.37M-70.98M-88.41M-31.95M118.76M-30.13M-22.50M-17.52M-16.08M-9.89M-9.12M-7.34M
EBITDA Margin-1,783.03%-2,100.53%-13,534.78%-15,308.93%-4,822.01%-4,922.55%-18,201.03%-2,507.23%-88.39%71.56%-2,756.27%-1,333.43%-935.84%-773.30%-1,059.42%-1,440.92%0.00%
EBIT-34.06M-30.20M-31.07M-19.64M-42.93M-60.51M-72.39M-90.49M-33.54M117.66M-31.02M-24.07M-18.00M-16.61M-9.81M-9.41M-7.58M
EBIT Margin-1,660.80%-1,982.99%-13,506.96%-11,688.10%-4,586.22%-5,017.50%-18,561.79%-2,566.34%-92.79%70.90%-2,837.79%-1,426.85%-961.75%-799.13%-1,050.11%-1,487.05%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙